// App-Quantinova.ai

SP0012 : COMPLEMENT IN THE RHEUMATIC DISEASE: COMPLEMENTOPATHIES

Researchers

Presenter

  • M. C. Pickering

Principal Investigators

  • N/A

Medical Centers

  • Centre for Complement & Inflammation Research, Imperial College, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Blood/haematological Diseases

Disease

  • Paroxysmal nocturnal hemoglobinuria

  • Lupus

  • Hemolytic–uremic syndrome

  • C3 glomerulopathy

  • Venous thrombosis

  • Atypical hemolytic uremic syndrome

Biomarkers

  • N/A

Drug/Treatment

  • Eculizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved